Changes in the liver parenchyma after proton beam radiotherapy: evaluation with MR imaging-Reference-Cited by-同舟云学术

Changes in the liver parenchyma after proton beam radiotherapy: evaluation with MR imaging

Published:2000-07 Issue:6 Volume:18 Page:707-714
ISSN:0730-725X
Container-title:Magnetic Resonance Imaging
language:en
Short-container-title:Magnetic Resonance Imaging

Author:

Onaya Hiroaki,Itai Yuji,Yoshioka Hiroshi,Ahmadi Tayeb,Niitsu Mamoru,Okumura Toshiyuki,Akine Yasuyuki,Matsuzaki Yasushi,Doi Mikio,Tsuji Hiroshi,Tsujii Hirohiko

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Biomedical Engineering,Biophysics

Reference25 articles.

1. Clinical results of fractionated proton therapy;Tsujii;Int J Radiat Oncol Biol Phys,1992

2. Proton irradiation for hepatocellular carcinoma;Tanaka;Lancet,1992

3. A new, effective and safe therapeutic option using proton irradiation for hepatocellular carcinoma;Matsuzaki;Gastroenterology,1994

4. Evaluation of the clinical applicability of proton beams in definitive fractionated radiation therapy;Suit;Int J Radiat Oncol Biol Phys,1982

5. Increased efficacy of radiation therapy by use of proton beam;Suit;Strahlenther Onkol,1990

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT;The British Journal of Radiology;2020-01

2. Image-guided Treatment in the Hepatobiliary System: Role of Imaging in Treatment Planning and Posttreatment Evaluation;RadioGraphics;2015-09

3. In vivoproton range verification: a review;Physics in Medicine and Biology;2013-07-17

4. Post-therapeutic needle biopsy in patients with hepatocellular carcinoma is a useful tool to evaluate response to proton irradiation;Hepatology Research;2013-05-10

5. Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients;Radiotherapy and Oncology;2013-03